4//SEC Filing
Priebe Waldemar 4
Accession 0001683168-22-000460
CIK 0001729427other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 4:05 PM ET
Size
5.4 KB
Accession
0001683168-22-000460
Insider Transaction Report
Form 4
Priebe Waldemar
10% Owner
Transactions
- Other
Common Stock
2020-05-05−1,495,867→ 7,533,133 total(indirect: See footnote)
Footnotes (2)
- [F1]The shares are held by a limited liability company for which the reporting person's adult child is the sole manager and adult children are sole members. Prior to May 5, 2020, the reporting person was a manager of the limited liability company. The reporting person ceased to be a manager of the limited liability company on May 5, 2020, and since such date has not had any voting or dispositive power over the shares held by the limited liability company. The reporting person has never had a pecuniary interest in the limited liability company.
- [F2]Consists of: (i) 7,333,133 shares of common stock held by a limited liability company; and (ii) 200,000 shares held by Houston Pharmaceuticals, Inc.
Documents
Issuer
CNS Pharmaceuticals, Inc.
CIK 0001729427
Entity typeother
Related Parties
1- filerCIK 0001678516
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 4:05 PM ET
- Size
- 5.4 KB